-
公开(公告)号:US20110124672A1
公开(公告)日:2011-05-26
申请号:US12912840
申请日:2010-10-27
申请人: Hui-Fang Chang , Yan Li , Eifion Phillips
发明人: Hui-Fang Chang , Yan Li , Eifion Phillips
IPC分类号: A61K31/439 , A61P25/18 , A61P25/00 , A61P25/28 , A61P25/24 , A61P25/34 , A61P25/30 , A61P25/04 , A61P29/00
CPC分类号: C07D491/22
摘要: Compounds of formula I: and pharmaceutically-acceptable salts thereof, wherein Ar and R are as defined in the specification, compositions containing such compounds and the use of such compounds and compositions for use in therapy.
摘要翻译: 式I化合物及其药学上可接受的盐,其中Ar和R如说明书中所定义,含有这些化合物的组合物以及用于治疗的这些化合物和组合物的用途。
-
公开(公告)号:US07514567B2
公开(公告)日:2009-04-07
申请号:US10563271
申请日:2004-07-06
申请人: Hui-Fang Chang , Eifion Phillips
发明人: Hui-Fang Chang , Eifion Phillips
IPC分类号: A61K31/421 , A61K31/422 , A61K31/424 , C07D413/02 , C07D498/10
CPC分类号: C07D498/20
摘要: Compounds of formula I: and pharmaceutically-acceptable salts thereof, wherein Q, Ar1, A and Ar2 are as defined in the specification, pharmaceutical compositions and formulations containing them, methods of using them to treat diseases and conditions either alone or in combination with other therapeutically-active compounds or substances, processes and intermediates used to prepare them, uses of them as medicaments for therapy, uses of them in the manufacture of medicaments and uses of them for diagnostic and analytic purposes.
摘要翻译: 式I化合物及其药学上可接受的盐,其中Q,Ar1,A和Ar2如说明书中所定义,药物组合物和含有它们的制剂,使用它们单独或与其它组合一起治疗疾病和病症的方法 用于制备它们的治疗活性化合物或物质,方法和中间体,它们作为治疗药物的用途,它们在制备药物中的用途以及它们用于诊断和分析目的的用途。
-
公开(公告)号:US20090018112A1
公开(公告)日:2009-01-15
申请号:US12199034
申请日:2008-08-27
申请人: Marc J. Chapdelaine , Cyrus J. Ohnmacht , Christopher Becker , Hui-Fang Chang , Bruce T. Dembofsky
发明人: Marc J. Chapdelaine , Cyrus J. Ohnmacht , Christopher Becker , Hui-Fang Chang , Bruce T. Dembofsky
IPC分类号: A61K31/506 , A61P25/22 , A61P25/00 , C07D237/26 , A61K31/502 , C07D401/02
CPC分类号: C07D237/28 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/10 , C07D405/04 , C07D409/04
摘要: This invention relates to novel compounds having the structural formula I below: and their pharmaceutically acceptable salts, tautomers or in vivo-hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of anxiety disorders, cognitive disorders, and/or mood disorders.
摘要翻译: 本发明涉及具有以下结构式I的新化合物及其药学上可接受的盐,互变异构体或体内可水解的前体,组合物及其使用方法。 这些新化合物提供治疗或预防焦虑症,认知障碍和/或情绪障碍。
-
公开(公告)号:US07417050B2
公开(公告)日:2008-08-26
申请号:US10511525
申请日:2003-04-15
申请人: Hui-Fang Chang , Eifion Phillips
发明人: Hui-Fang Chang , Eifion Phillips
IPC分类号: A61K31/44 , C07D401/04
CPC分类号: C07D491/22
摘要: Compounds of formula I: and pharmaceutically-acceptable salts thereof, wherein Ar and R are as defined in the specification, compositions containing such compounds and the use of such compounds and compositions for use in therapy.
摘要翻译: 式I化合物及其药学上可接受的盐,其中Ar和R如说明书中所定义,含有这些化合物的组合物以及用于治疗的这些化合物和组合物的用途。
-
公开(公告)号:US07417049B2
公开(公告)日:2008-08-26
申请号:US10511535
申请日:2003-04-15
申请人: Hui-Fang Chang , Yan Li , Eifion Phillips
发明人: Hui-Fang Chang , Yan Li , Eifion Phillips
IPC分类号: C07D401/04 , C07D401/14 , A61K43/08
CPC分类号: C07D491/22
摘要: Compounds of formula I: and pharmaceutically-acceptable salts thereof, wherein Ar and R are as defined in the specification, compositions containing such compounds and methods of using such compounds and compositions in therapy.
摘要翻译: 式I化合物及其药学上可接受的盐,其中Ar和R如说明书中所定义,含有这些化合物的组合物以及在治疗中使用这些化合物和组合物的方法。
-
公开(公告)号:US20080139600A1
公开(公告)日:2008-06-12
申请号:US11749820
申请日:2007-05-17
申请人: Hui-Fang Chang , Christopher Holmquist , Eifion Phillips , Timothy Piser , Thomas Simpson , Rebecca Urbanek , James Woods , Hui Xiong
发明人: Hui-Fang Chang , Christopher Holmquist , Eifion Phillips , Timothy Piser , Thomas Simpson , Rebecca Urbanek , James Woods , Hui Xiong
IPC分类号: A61K31/439 , A61P25/00 , A61P25/22 , A61P25/28 , A61P25/30 , A61P25/18 , C07D491/22
CPC分类号: C07D491/22
摘要: Nicotinic acetylcholine receptor ligands of Formula I wherein X, n, R1 and R2 are as described in the specification, diastereoisomers, enantiomers, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing, and methods for using the same.
摘要翻译: 式I的烟碱型乙酰胆碱受体配体,其中X,n,R 1和R 2如说明书中所述,非对映异构体,对映异构体,药学上可接受的盐,制备方法 ,含有的药物组合物及其使用方法。
-
公开(公告)号:US20090036454A1
公开(公告)日:2009-02-05
申请号:US12169824
申请日:2008-07-09
申请人: Marc J. Chapdelaine , Cyrus J. Ohnmacht , Christopher Becker , Hui-Fang Chang , Bruce T. Dembofsky
发明人: Marc J. Chapdelaine , Cyrus J. Ohnmacht , Christopher Becker , Hui-Fang Chang , Bruce T. Dembofsky
IPC分类号: A61K31/502 , C07D237/28 , A61P25/00 , A61P25/28 , C07K14/705
CPC分类号: C07D237/28 , C07D401/10 , C07D401/14 , C07D403/04 , C07D403/10 , C07D405/10 , C07D405/12 , C07D405/14 , C07D409/04
摘要: This invention relates to novel compounds having the structural formula I below: and their pharmaceutically acceptable salts, tautomers or in vivo-hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of anxiety disorders, cognitive disorders, and/or mood disorders.
-
公开(公告)号:US07425556B2
公开(公告)日:2008-09-16
申请号:US11611936
申请日:2006-12-18
申请人: Marc J. Chapdelaine , Cyrus J. Ohnmacht , Christopher Becker , Hui-Fang Chang , Bruce T. Dembofsky
发明人: Marc J. Chapdelaine , Cyrus J. Ohnmacht , Christopher Becker , Hui-Fang Chang , Bruce T. Dembofsky
IPC分类号: A61K31/502 , A61K31/498 , C07D237/28 , A61P25/22
CPC分类号: C07D237/28 , C07D401/10 , C07D401/14 , C07D403/04 , C07D403/10 , C07D405/10 , C07D405/12 , C07D405/14 , C07D409/04
摘要: This invention relates to novel compounds having the structural formula I below: and their pharmaceutically acceptable salts, tautomers or in vivo-hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of anxiety disorders, cognitive disorders, and/or mood disorders.
-
公开(公告)号:US20070142328A1
公开(公告)日:2007-06-21
申请号:US11611936
申请日:2006-12-18
IPC分类号: A61K31/695 , A61K31/502 , C07F7/02 , C07D237/28
CPC分类号: C07D237/28 , C07D401/10 , C07D401/14 , C07D403/04 , C07D403/10 , C07D405/10 , C07D405/12 , C07D405/14 , C07D409/04
摘要: This invention relates to novel compounds having the structural formula I below: and their pharmaceutically acceptable salts, tautomers or in vivo-hydrolysable precursors, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of anxiety disorders, cognitive disorders, and/or mood disorders.
摘要翻译: 本发明涉及具有以下结构式I的新化合物及其药学上可接受的盐,互变异构体或体内可水解的前体,组合物及其使用方法。 这些新化合物提供治疗或预防焦虑症,认知障碍和/或情绪障碍。
-
公开(公告)号:US07186836B2
公开(公告)日:2007-03-06
申请号:US10511522
申请日:2003-04-15
申请人: Hui-Fang Chang , Yan Li , Eifion Phillips
发明人: Hui-Fang Chang , Yan Li , Eifion Phillips
IPC分类号: C07D401/14 , C07D401/04 , C07D333/02 , C07D333/50
CPC分类号: C07D491/22
摘要: A compound having the formula I: and pharmaceutically-acceptable salts thereof, wherein Ar and R are as defined in the specification, compositions containing such compounds and the use of such compounds and compositions for use in therapy.
摘要翻译: 具有式I的化合物及其药学上可接受的盐,其中Ar和R如本说明书中所定义,含有这些化合物的组合物以及用于治疗的这些化合物和组合物的用途。
-
-
-
-
-
-
-
-
-